Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Loss of β-arrestin2 in D2 cells alters neuronal excitability in the nucleus accumbens and behavioral responses to psychostimulants and opioids.

Porter-Stransky KA, Petko AK, Karne SL, Liles LC, Urs NM, Caron MG, Paladini CA, Weinshenker D.

Addict Biol. 2019 Aug 23:e12823. doi: 10.1111/adb.12823. [Epub ahead of print]

PMID:
31441201
2.

Selective D2 and D3 receptor antagonists oppositely modulate cocaine responses in mice via distinct postsynaptic mechanisms in nucleus accumbens.

Manvich DF, Petko AK, Branco RC, Foster SL, Porter-Stransky KA, Stout KA, Newman AH, Miller GW, Paladini CA, Weinshenker D.

Neuropsychopharmacology. 2019 Jul;44(8):1445-1455. doi: 10.1038/s41386-019-0371-2. Epub 2019 Mar 16.

PMID:
30879021
3.

Noradrenergic Transmission at Alpha1-Adrenergic Receptors in the Ventral Periaqueductal Gray Modulates Arousal.

Porter-Stransky KA, Centanni SW, Karne SL, Odil LM, Fekir S, Wong JC, Jerome C, Mitchell HA, Escayg A, Pedersen NP, Winder DG, Mitrano DA, Weinshenker D.

Biol Psychiatry. 2019 Feb 1;85(3):237-247. doi: 10.1016/j.biopsych.2018.07.027. Epub 2018 Aug 17.

PMID:
30269865
4.

In vivo detection of optically-evoked opioid peptide release.

Al-Hasani R, Wong JT, Mabrouk OS, McCall JG, Schmitz GP, Porter-Stransky KA, Aragona BJ, Kennedy RT, Bruchas MR.

Elife. 2018 Sep 3;7. pii: e36520. doi: 10.7554/eLife.36520.

5.

LSD1 protects against hippocampal and cortical neurodegeneration.

Christopher MA, Myrick DA, Barwick BG, Engstrom AK, Porter-Stransky KA, Boss JM, Weinshenker D, Levey AI, Katz DJ.

Nat Commun. 2017 Oct 9;8(1):805. doi: 10.1038/s41467-017-00922-9.

6.

Arresting the Development of Addiction: The Role of β-Arrestin 2 in Drug Abuse.

Porter-Stransky KA, Weinshenker D.

J Pharmacol Exp Ther. 2017 Jun;361(3):341-348. doi: 10.1124/jpet.117.240622. Epub 2017 Mar 16. Review.

7.

Dopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bonds.

Resendez SL, Keyes PC, Day JJ, Hambro C, Austin CJ, Maina FK, Eidson LN, Porter-Stransky KA, Nevárez N, McLean JW, Kuhnmuench MA, Murphy AZ, Mathews TA, Aragona BJ.

Elife. 2016 Jul 2;5. pii: e15325. doi: 10.7554/eLife.15325.

8.

Individual differences in orexin-I receptor modulation of motivation for the opioid remifentanil.

Porter-Stransky KA, Bentzley BS, Aston-Jones G.

Addict Biol. 2017 Mar;22(2):303-317. doi: 10.1111/adb.12323. Epub 2015 Nov 24.

9.

Rapid dopamine transmission within the nucleus accumbens: dramatic difference between morphine and oxycodone delivery.

Vander Weele CM, Porter-Stransky KA, Mabrouk OS, Lovic V, Singer BF, Kennedy RT, Aragona BJ.

Eur J Neurosci. 2014 Oct;40(7):3041-3054. doi: 10.1111/ejn.12709. Epub 2014 Sep 11.

10.

Development of behavioral preferences for the optimal choice following unexpected reward omission is mediated by a reduction of D2-like receptor tone in the nucleus accumbens.

Porter-Stransky KA, Seiler JL, Day JJ, Aragona BJ.

Eur J Neurosci. 2013 Aug;38(4):2572-88. doi: 10.1111/ejn.12253. Epub 2013 May 22.

11.

Chemical gradients within brain extracellular space measured using low flow push-pull perfusion sampling in vivo.

Slaney TR, Mabrouk OS, Porter-Stransky KA, Aragona BJ, Kennedy RT.

ACS Chem Neurosci. 2013 Feb 20;4(2):321-9. doi: 10.1021/cn300158p. Epub 2012 Nov 16.

12.

Cocaine must enter the brain to evoke unconditioned dopamine release within the nucleus accumbens shell.

Porter-Stransky KA, Wescott SA, Hershman M, Badrinarayan A, Vander Weele CM, Lovic V, Aragona BJ.

Neurosci Lett. 2011 Oct 17;504(1):13-7. doi: 10.1016/j.neulet.2011.08.028. Epub 2011 Aug 24.

PMID:
21888949

Supplemental Content

Loading ...
Support Center